Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Cenovus Stock Could Still Double This Year

Published 2021-06-09, 11:30 a/m
Updated 2021-06-09, 11:45 a/m
Why Cenovus Stock Could Still Double This Year

Along with several other companies, Cenovus (TSX:CVE)(NYSE:CVE) has felt the pandemic’s wrath — in a big way.

However, of late, this stock has really shown what it’s made of. Cenovus has seen its stock price approximately double over the past year. And that’s not by accident.

Indeed, it appears investors are gravitating toward value stocks like never before. And Cenovus’s valuation has been hit much harder than many argue it should have during the pandemic.

Here’s why this recovery may only still be in its early innings for this Canadian energy player.

Optimistic prospects more than offsetting bearish catalysts Bears have noted that Cenovus’s one-time balance sheet hit it took when acquiring Husky was too big to ignore. Indeed, this business combination was one investors chose to steer clear of. And that certainly makes sense. The debt profile for the combined company required some re-jigging to make the deal make sense. Accordingly, Cenovus found itself monetizing non-core assets to make this deal happen. Some investors didn’t like the structure of the deal, nor what was left when it was all said and done.

However, the overhang from this deal is more than fully priced in at these levels. Debt concerns, which were once massive issues when oil was trading where it was (it was actually negative for a short period of time) became even more problematic. However, with oil prices now hovering around US$70 WTI, these concerns seem to be less of an issue today.

If Cenovus can increase its cash flows as expected as a result of this deal, the Husky acquisition could turn out to be a great move over the long term. Time will tell. However, right now, things look much more optimistic for Cenovus than at any point during the past year.

Bottom line on Cenovus stock With the one-time integration cost of US$245 million tied to the Husky deal behind Cenovus, investors can look forward to some impressive cash flow growth on the horizon.

Well, Cenovus still managed to book a profit of US$200 million this past quarter, despite impairment charges. As long as oil doesn’t nosedive anytime soon, Cenovus still looks very cheap here. Accordingly, I think value investors sniffing around for deals will isolate companies like Cenovus for some time to come.

Indeed, it’s not to late to pick up shares of Cenovus around $12 per share. In fact, at this level, I think much more upside could be on the horizon. The company has front-loaded its negative news and is poised to increase production over the near to medium term. For investors bullish on energy, this is one place to be right now.

The post Why Cenovus Stock Could Still Double This Year appeared first on The Motley Fool Canada.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.